Considering the current technology available, the best option may be to test for Hp phenotypes in blood donors and compare Hp phenotypes (e.g., Hp 1F-1F) theorized to be advantageous with Hp 2-2 for transfusion of patients with SCD. The gene discussed is HP; the disease is Schnyder corneal dystrophy.